Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Simultaneous cardiac imaging to detect inflammation and scar tissue with (18)F-fluorodeoxyglucose PET/MRI in cardiac sarcoidosis.

Literature DB >> 26626783

Simultaneous cardiac imaging to detect inflammation and scar tissue with (18)F-fluorodeoxyglucose PET/MRI in cardiac sarcoidosis.

Kento Wada^1,2, Takeo Niitsuma², Takayoshi Yamaki¹, Atsuro Masuda¹, Hiroshi Ito³, Hitoshi Kubo³, Takamitsu Hara³, Seiichi Takenoshita³, Yasuchika Takeishi⁴.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2015 PMID： 26626783 DOI： 10.1007/s12350-015-0348-4

Source DB: PubMed Journal: J Nucl Cardiol ISSN： 1071-3581 Impact factor: 5.952

× No keyword cloud information.

3 in total

1. Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment.

Authors: Simon Schneider; Anja Batrice; Christoph Rischpler; Matthias Eiber; Tareq Ibrahim; Stephan G Nekolla
Journal: Eur Heart J Date: 2013-08-23 Impact factor: 29.983

Review 2. PET/MRI of the heart.

Authors: Christoph Rischpler; Stephan G Nekolla; Karl P Kunze; Markus Schwaiger
Journal: Semin Nucl Med Date: 2015-05 Impact factor: 4.446

3. Potential Applications of PET/MR Imaging in Cardiology.

Authors: Osman Ratib; René Nkoulou
Journal: J Nucl Med Date: 2014-04-24 Impact factor: 10.057

3 in total

12 in total

1. Assessment of myocardial viability of a patient with old myocardial infarction by ¹⁸F-fluorodeoxyglucose PET/MRI.

Authors: Atsuro Masuda; Ayaka Nemoto; Takayoshi Yamaki; Noboru Oriuchi; Seiichi Takenoshita; Yasuchika Takeishi
Journal: J Nucl Cardiol Date: 2017-06-05 Impact factor: 5.952

2. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors: Wael A AlJaroudi; Fadi G Hage
Journal: J Nucl Cardiol Date: 2019-01-02 Impact factor: 5.952

3. Cardiac imaging with ¹⁸F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy.

Authors: Yasuchika Takeishi; Atsuro Masuda; Hitoshi Kubo; Hideyuki Tominaga; Noboru Oriuchi; Seiichi Takenoshita
Journal: J Nucl Cardiol Date: 2016-10-14 Impact factor: 5.952

4. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.

Authors: Riemer H J A Slart; Andor W J M Glaudemans; Patrizio Lancellotti; Fabien Hyafil; Ron Blankstein; Ronald G Schwartz; Wael A Jaber; Raymond Russell; Alessia Gimelli; François Rouzet; Marcus Hacker; Olivier Gheysens; Sven Plein; Edward J Miller; Sharmila Dorbala; Erwan Donal
Journal: J Nucl Cardiol Date: 2018-02 Impact factor: 5.952

Review 10. Cardiac PET/MRI-an update.

Authors: C Rischpler; S G Nekolla; G Heusch; L Umutlu; T Rassaf; P Heusch; K Herrmann; F Nensa
Journal: Eur J Hybrid Imaging Date: 2019-01-22

Simultaneous cardiac imaging to detect inflammation and scar tissue with (18)F-fluorodeoxyglucose PET/MRI in cardiac sarcoidosis.

1. Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment.

Review 2. PET/MRI of the heart.

3. Potential Applications of PET/MR Imaging in Cardiology.

1. Assessment of myocardial viability of a patient with old myocardial infarction by ¹⁸F-fluorodeoxyglucose PET/MRI.

2. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

3. Cardiac imaging with ¹⁸F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy.

4. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.

Review 5. Positron emission tomography/MRI for cardiac diseases assessment.

Review 6. Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Review 7. Updates on the Role of Imaging in Cardiac Sarcoidosis.

Review 8. PET-CMR in heart failure - synergistic or redundant imaging?

9. Somatostatin receptor based hybrid imaging in sarcoidosis.

Review 10. Cardiac PET/MRI-an update.